{"id":"W2754728664","doi":"10.1136/annrheumdis-2017-eular.1274","title":"OP0222 Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 104 weeks results from a phase 3 trial, future 2","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Secukinumab; Medicine; Psoriatic arthritis; Dactylitis; Placebo; Internal medicine; Ankylosing spondylitis; Gastroenterology; Enthesitis; Rheumatoid arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001988428,0.00144229,0.002079837,0.0003858105,0.0005170418,0.001324568,0.0006275827,0.001897798,0.005820059],"category_scores_gemma":[0.0009553463,0.0004811699,0.002593484,0.0003060825,0.0007468822,0.00101058,0.0002893164,0.003038396,0.001177435],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005242719,"about_ca_system_score_gemma":0.000771574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008666868,"about_ca_topic_score_gemma":0.002354668,"domain_scores_codex":[0.9993481,0.0002719376,0.00003882155,0.00008008832,0.0000831563,0.0001778926],"domain_scores_gemma":[0.9994075,0.0001318873,0.0001184356,0.00005855132,0.00005395601,0.0002296596],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.729891,0.04486096,0.002986065,0.001446154,0.002373893,0.0003706147,0.0002746342,0.001317455,0.03687434,0.0002660853,0.00801206,0.1713268],"study_design_scores_gemma":[0.4996617,0.4718471,0.01745441,0.0001251777,0.001062697,0.0004046694,0.0001038429,0.0009179502,0.004533463,0.0002889697,0.003532319,0.00006774834],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9831995,0.009128906,0.0006522234,0.001178675,0.0003307874,0.001087393,0.001457988,0.0001880633,0.002776503],"genre_scores_gemma":[0.9809573,0.005313729,0.001733177,0.002046764,0.0004297166,0.001302025,0.002416835,0.00006125812,0.005739145],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005820059,"threshold_uncertainty_score":0.01947004,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02937615795444619,"score_gpt":0.331369886370903,"score_spread":0.3019937284164568,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}